Smead Capital Management disclosed 27 US equity positions worth $127.7m in its Q3 2009 13F filing. Its largest position is Smead Value Fd at 14.4% of the reported book, followed by MSFT and Merck & Co Inc. Versus Q2 2009 it opened 1 new position, added to 22, reduced 2 and exited 3.
$128m
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
27
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
14.4%
Largest position
The largest single position as a share of the reported equity book.
61.7%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
17
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.